Loading...
OTCM
BIMI
Market cap1kUSD
Jul 08, Last price  
0.00USD
1D
0.00%
1Q
-99.00%
Jan 2017
-100.00%
IPO
-100.00%
Name

Bimi International Medical Inc

Chart & Performance

D1W1MN
OTCM:BIMI chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
79.89%
Rev. gr., 5y
6.82%
Revenues
12m
-44.51%
0005,269,00010,336,00015,835,00020,324,00025,372,00014,929,0009,269,0005,675,0009,981,0006,715,0006,041,0008,508,0006,542,000157,97812,845,00021,320,00011,830,000
Net income
-22m
L-35.99%
-292,000-344,357-399,259790,9612,069,0003,653,0004,776,0004,303,0002,046,00088,034-180,000-617,000-969,000-1,818,000-1,570,000-16,787,000-4,439,000-5,293,435-34,986,000-22,393,000
CFO
-10m
L+703.87%
-190,470-363,546-176,677-1,255,750776,595-12,5122,929,8983,359,9982,488,5734,559,248892,708-995,080-2,473,729159,832-908,229-343,970-2,064,792-3,517,733-1,275,725-10,255,206

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products. Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region. The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.
IPO date
Oct 04, 2010
Employees
296
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT